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Summary Heat sensitivity and the development of thermotolerance of cells isolated directly from surgical
specimens of human breast carcinoma, malignant melanoma and squamous cell carcinoma of the head and
neck were studied in vitro using the Courtenay soft agar colony assay. The plating efficiency of some of the
tumours was sufficiently high (0.3-20.4%) for survival curves covering up to two to three decades to be
established. Experiments repeated with cells stored in liquid nitrogen showed that the survival assay gave
highly reproducible results. Heat sensitivity of thermotolerant cells was studied by giving cells a conditioning
heat treatment of 43.5°C for 60 min and, after incubation at 37C for 24 h, second graded heat treatments at
43.5'C. Significant differences in heat sensitivity and development of thermotolerance between the three
tumour types were not found. However, the heat sensitivity, whether the cells were thermotolerant or not,
differed considerably among individual tumours of each histological category. Do at 43.5°C was found to be in
the ranges of 23-59 min (breast carcinoma), 20-63 min (malignant melanoma) and 20-57 min (squamous cell
carcinoma) for single-heated cells and 105-476 min (breast carcinoma), 102-455 min (malignant melanoma)
and 87-400 min (squamous cell carcinoma) for thermotolerant cells. The heat sensitivity of cells made
thermotolerant showed no significant correlation to the surviving fraction after the conditioning heat treat-
ment. The study indicated that histological category is a poor parameter for assessment of clinical heat
responsiveness of tumours. Breast carcinoma, malignant melanoma and squamous cell carcinoma are prob-
ably, from a thermobiological point of view, equally good candidates for clinical trials aimed at studying the
potential usefulness of hyperthermia as an adjunct to radiation therapy and/or chemotherapy. The large
differences in heat sensitivity and development of thermotolerance observed among individual tumours,
irrespective of histological origin, suggested that an in vitro predictive assay for heat responsiveness would be
very useful for stratification purposes in such clinical trials.
Experimental investigations including studies of transplant-
able tumours in small rodents and spontaneous tumours in
pet animals have indicated that hyperthermia may become a
useful modality for treatment of human cancer (Hahn, 1982;
Storm, 1983). Heat is cytotoxic to tumour cells, potentiates
the effects of ionising radiation and enhances the uptake and
cytotoxicity of some chemotherapeutic agents. Clinical inves-
tigations of hyperthermia have been hampered by lack of
adequate heating and thermometry technology. However,
small superficial tumours can often be heated to therapeutic
temperatures by use of ultrasound, microwaves or interstitial
techniques (Hand & ter Haar, 1981). Clinical thermo-
radiotherapy studies of breast carcinoma, malignant
melanoma and squamous cell carcinoma of the head and
neck have been initiated in several therapeutic centers (Perez
et al., 1986; Valdagni et al., 1986; Emami et al., 1988).
The thermobiology of cells in culture has been studied
extensively, and important information relevant to hyper-
thermic treatment of cancer has been obtained (Hahn, 1982;
Storm, 1983). First, heat survival curves in vitro show the
same shape as X-ray survival curves, i.e. the curves possess a
small initial shoulder followed by an exponential portion
(Westra & Dewey, 1971). Second, heat sensitivity differs con-
siderably among cell lines (Raaphorst et al., 1979) and is
enhanced at low pH (Gerweck, 1977). Moreover, heat
induces a transient, non-heritable resistance to subsequent
heat exposure (Gerner & Schneider, 1975); the phenomenon
is called thermotolerance and may limit the success of clinical
hyperthermia (Henle, 1987). However, most thermobiological
studies in vitro have been performed using cell lines estab-
lished from rodent tumours and normal tissues, and such
cells are not necessarily representative for human tumours in
every respect. In fact, there are some indications that human
tumour cells may be more heat resistant than rodent cells,
possibly because of a difference in the normal body
temperature between rodents and humans (Raaphorst et al.,
1979; Roizin-Towle et al., 1986). The benefits of using human
tumour cells in therapy-related, radiobiological studies are
well recognised (Deacon et al., 1984; Fertil & Malaise, 1985).
Similarly, there is a need for systematic thermobiological
studies in vitro involving human tumour cells of different
histological origin.
The thermobiology of human tumour cells is currently
being studied in our laboratory (Rofstad et al., 1984; Rofstad
& Brustad, 1986a). Cells have been isolated directly from
xenografted tumours, heated in vitro, and assayed for sur-
vival using the Courtenay soft agar colony assay (Courtenay
& Mills, 1978). Comparative studies have indicated that this
assay is superior to other clonogenic assays for cells isolated
directly from solid tumours (Courtenay et al., 1978; Tveit et
al., 1981). This assay has also been used in our laboratory in
studies of the radiation sensitivity of cells isolated directly
from human tumour surgical specimens (Rofstad et al.,
1987). The heat sensitivity of cells from seven human
melanoma surgical specimens has also been reported in a
preliminary communication (Rofstad et al., 1985). Heat sen-
sitivity and development of thermotolerance of cells isolated
directly from surgical specimens of patients with breast car-
cinoma, malignant melanoma and squamous cell carcinoma
of the head and neck are reported here. These tumour types
were selected because they are considered to be the best
candidates for clinical thermoradiotherapy studies at the
present stage of development of hyperthermia technology.
The main purpose of the work was to investigate whether
one of these histological categories might be more responsive
to heat treatment than the others, and thus would be the
tumour type of choice for clinical trials.
Materials and methods
Tumour tissue
Tumour tissue specimens were dropped into culture medium
(4°C) immediately after surgery and brought to the
laboratory. Normal tissue and necrotic areas were removed
with scalpels. The tumour tissue was cut into fragments,
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suspended in 20 ml culture medium in a plastic bag, and
treated for 30 s with a stomacher (Lab-Blender 80; Seward
Laboratory, London, UK). After the mechanical disaggrega-
tion, some of the tumour specimens were disaggregated fur-
ther by treatment with an enzyme mixture containing 0.02%
collagenase I, 0.05% pronase and 0.02% DNase for
20-60 min at 37C. The suspensions were then filtered
through 45-tim nylon mesh before centrifugation and
resuspension in culture medium. The quality of the suspen-
sions was examined using a phase contrast microscope. A
haemocytometer was used to determine the fraction of single
cells, doublets and cell aggregates. Only morphologically
intact, viable cells, i.e. cells having an intact and smooth
outline with a bright halo, were counted. Heat sensitivity
experiments were performed only if the fraction of doublets
was <5% and the fraction of larger aggregates was
<0.1%. Other cell suspensions were discarded. The prob-
ability of obtaining an acceptable cell suspension increased
with increasing size of the surgical specimen. It was generally
difficult to isolate cell suspensions of sufficient quality from
specimens < 1-2 cm3. When the cell yield was high, some of
the cells were frozen in liquid nitrogen and stored. The
remaining cell suspension was diluted to appropriate concen-
trations in culture medium and used in survival experiments
within a few hours.
Colony assay
Cell survival following heat treatment (see below) was
measured using the Courtenay soft agar colony assay
(Courtenay & Mills, 1978). The soft agar was prepared from
powdered agar (Bacto agar; Difco, Detroit, MI, USA) and
culture medium (Ham's F12 medium with 20% fetal calf
serum, penicillin (250 mg 1'), and streptomycin (50 mg I'),
all from Gibco-Biocult, Glasgow, UK). Erythrocytes from
August rats were added as described previously (Rofstad,
1981). Aliquots of I ml of soft agar with the appropriate
number of tumour cells were seeded in plastic tubes (Falcon
2057 tubes; Falcon Labware, Becton Dickinson and Co.,
Oxnard, CA, USA). The cells were incubated at 37°C for
4-5 weeks in an atmosphere of 5% 02, 5% CO2 and 90%
N2. Culture medium (2 ml) was added on the top of the agar
5 days after seeding and then changed weekly. Cells giving
rise to colonies containing more than 50 cells were scored as
clonogenic. Colonies were counted using a stereomicroscope.
Plating efficiency was calculated from the number of colonies
counted and the number of morphologically intact, viable
single cells seeded.
Care was taken to avoid potential pitfalls inherent in the
Courtenay assay when used to study survival of cells isolated
directly from human tumour surgical specimens (Rofstad et
al., 1985). To begin with, preliminary experiments had shown
that the plating efficiency of some tumours depended on the
number of cells seeded. An equal number of cells per tube
was therefore seeded for all heating times for a given tumour,
usually in the range of 50,000-100,000, depending on the cell
yield. In addition, one or two lower levels, usually in the
range of 2,000-15,000 cells per tube, were seeded for un-
treated cells and cells given short heat treatments. Generally,
the plating efficiency and all survival levels were calculated
from the number of colonies in the tubes with the highest cell
number. However, in a few cases when the plating efficiency
was high, the plating efficiency and the survival levels at the
shorter heating times were calculated from the tubes with one
of the lower cell numbers, whereas the survival levels at the
longer heating times were calculated from the tubes with the
highest cell number. A linear relationship between number of
colonies and number of cells seeded was always verified when
this procedure was used.
Preliminary investigations had revealed that cell clumps in
the soft agar could erroneously lead to survival curves with a
shallow tail. Tumour specimens giving cell suspensions with a
significant fraction of doublets and aggregates were therefore
not subjected to heat sensitivity studies (see above). Further-
more, artificial colonies due to cell clumps were searched for
by examining soft agar cultures of cells given a lethal heat
treatment (46°C for 3 h), but were never seen. It was not
found necessary to correct measured survival levels
mathematically for multiplicity.
Heat treatment
The cells were kept in soft agar in the plastic tubes men-
tioned above during the heat treatment. The tubes were
flushed with 5% C02, 5% 02and 90% N2 immediately after
the cells were seeded. The cells were then incubated at 37°C
for 3 h before starting the heat exposure, to avoid possible
interactions between the enzymatic cell disaggregation and
the heat treatment. Preliminary experiments had shown that
the heat sensitivity did not differ significantly for cells treated
3 h and 27 h after enzymatic disaggregation. The pH of the
soft agar was 7.4 during the heat treatment. The tubes were
immersed in a thermostatically regulated water bath, and
temperature equilibrium between the water bath and the soft
agar was obtained within 4 min.
Results
The kinetics of development of thermotolerance was studied
using cells isolated from three different human tumours: one
breast carcinoma, one malignant melanoma and one
squamous cell carcinoma of the head and neck (Figure 1).
The cells were given a conditioning heat treatment of 43.50C
for 60 min and, after incubation at 37°C for an interval
ranging from 8 to 32 h, a second heat treatment of43.50C for
120 min. For all tumours, the surviving fraction increased
with increasing fractionation interval up to about 24 h and
then decreased. The open symbols and the dashed lines in
Figure 1 show the surviving fractions after a single heat
treatment of 43.50C for 120 min, i.e. a treatment identical to
the second fraction in the split-treatment experiments.
Assuming complete repair of the heat damage caused by the
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Figure 1 Surviving fraction as a function of fractionation inter-
val for cells from a human breast carcinoma (A), malignant
melanoma (0) and squamous cell carcinoma of the head and
neck (M) given two heat treatments at 43.5°C in soft agar. The
first treatment lasted 60 min, and the second 120 min. -- -,
surviving fraction after a single heat treatment of 43.5°C for
120 min for the breast carcinoma (A), malignant melanoma (0)
and squamous cell carcinoma (0). Each survival level was cal-
culated from the mean number of colonies in four tubes with
heated and four tubes with unheated cells.24 E.K. ROFSTAD
first treatment and unchanged response to the second treat-
ment, surviving fractions at the levels of the dashed lines are
to be expected. However, the highest surviving fractions were
significantly higher than those indicated by the dashed lines.
This observation shows that the first treatment had induced
increased resistance to the second treatment, i.e. thermo-
tolerance had developed in the time interval between the two
treatments. The thermotolerance reached its maximum mag-
nitude about 24 h after the conditioning heat treatment in all
tumours.
Heat survival curves were determined for 14 breast car-
cinomas, 14 malignant melanomas and 14 squamous cell
carcinomas, all derived from different patients (Figures 2-4).
Figure 2 refers to cells given single heat treatments at 43.5°C
and Figure 3 to thermotolerant cells, i.e. the cells were given
a conditioning heat treatment of 43.5°C for 60 min and, after
incubation at 37°C for 24 h for development of thermo-
tolerance, second graded heat treatments at 43.5°C. Survival
curves for both single-heated and thermotolerant cells were
determined for two tumours of each histological category,
and Figure 4 refers to these tumours. The tumours showed a
sufficiently high plating efficiency that cell survival could be
measured over up to two to three decades. The plating
efficiencies ranged from 0.4 to 4.8% for the breast car-
cinomas, from 1.6 to 20.4% for the malignant melanomas
and from 0.3 to 3.5% for the squamous cell carcinomas
(Table I). The cell yield for some of the tumour specimens
was high enough for the experiments to be repeated with cell
samples stored in liquid nitrogen. Experiments with stored
cells gave similar plating efficiencies and similar survival
curves to experiments with newly prepared cell suspensions
(Figures 2-4). Single-heated cells showed exponential sur-
vival curves with a small initial shoulder. The shoulder was
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often absent or less pronounced for thermotolerant cells.
Exponential curves were fitted to the survival data beyond
the shoulder region by regression analysis. D. values for
single-heated and thermotolerant cells are presented in Tables
II and III, respectively. The survival curves differed con-
siderably among individual tumours of the same histological
category; D. was found to be in the ranges 23-59 min
(breast carcinoma), 20-63 min (malignant melanoma) and
20-57 min (squamous cell carcinoma) for single-heated cells
and 105-476 min (breast carcinoma), 102-455 min (malig-
nant melanoma) and 87-400 min (squamous cell carcinoma)
for thermotolerant cells. The thermotolerance ratios (TTR),
i.e. the ratios of the D. values for thermotolerant and single-
heated cells, were 3.8 ± 0.6 and 8.2 ± 4.2 for the two breast
carcinomas, 3.8 ± 0.9 and 7.6 ± 1.3 for the two malignant
melanomas and 4.4 ± 0.7 and 8.0 ± 5.4 for the two squamous
cell carcinomas presented in Figure 4. There were no statis-
tically significant differences between breast carcinoma,
malignant melanoma and squamous cell carcinoma in D.
values (single-heated as well as thermotolerant cells).
The heterogeneity in heat sensitivity within each his-
tological category is illustrated in Figure 5, which shows the
surviving fraction after 43.5°C for 60 min for all 42 tumours.
The surviving fractions covered a broad range from 0.080 to
0.60, and this range was almost identical for the three
tumour types. Figure 5 shows that possible differences in
cellular heat sensitivity between the three tumour types are
small compared to the differences among individual tumours
of a specific histological category.
A possible relationship between development of thermo-
tolerance and heat sensitivity was investigated by plotting D.
for thermotolerant cells versus surviving fraction after the
conditioning heat treatment, i.e. 43.5°C for 60 min (Figure 6).
Time at 43.5 °C (min)
Figure 2 Survival curves for cells from human breast carcinoma (a,b), malignant melanoma (c,d), and squamous cell carcinoma of
the head and neck (e,f) heated at 43.5°C in soft agar. Circles, triangles and squares in the same panel refer to different tumours. 0,
A, *, cells from newly prepared suspensions; 0, A, 0, cells stored in liquid nitrogen. Each survival level was calculated from the
mean number of colonies in four tubes with heated and four tubes with unheated cells.HYPERTHERMIA OF HUMAN TUMOUR CELLS 25
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Figure 3 Survival curves for cells from human breast carcinoma (a,b), malignant melanoma (c,d) and squamous cell carcinoma of
the head and neck (e,f) heated in soft agar. The cells were given a conditioning heat treatment of 43.5°C for 60 min and, after a
fractionation interval of 24 h, second graded heat treatments at 43.5°C. Circles, triangles and squares in the same panel refer to
different tumours. 0, A, *, cells from newly prepared suspensions; 0, A, 0, cells stored in liquid nitrogen. Each survival level
was calculated from the mean number of colonies in four tubes with heated and four tubes with unheated cells.
No clear correlation was found. Cells that were relatively
heat resistant after development of thermotolerance tended to
show high surviving fractions after the conditioning heat
treatment. However, thermotolerant cells that were relatively
heat sensitive showed surviving fractions after the condition-
ing heat treatment that covered the entire range of observed
values.
Discussion
The Courtenay soft agar colony assay was used to study heat
sensitivity and development of thermotolerance of cells
isolated directly from surgical specimens of human breast
carcinoma, malignant melanoma and squamous cell car-
cinoma of the head and neck. The plating efficiency varied
considerably among individual tumours, but was in some
cases sufficiently high for survival curves covering two to
three decades to be established (Table I). In other cases
colonies were not formed at all or the plating efficiency was
so low that heat sensitivity studies were not feasible. The
tumours in Table I constituted only about 2/3 (malignant
melanoma) and 1/3 (breast and squamous cell carcinoma) of
the total number of tumours subjected to heat treatment.
This rate of success was comparable to that reported for
tumours of other histological categories exposed to ionising
radiation (Rofstad et al., 1987). Thus, sensitivity to treatment
of cells isolated directly from surgical specimens can be
studied only in some human tumours by means of the
Courtenay assay.
Previous work has revealed some potential pitfalls in the
Courtenay assay; the plating efficiency may depend on the
number of tumour cells seeded, and the cell clumps present in
the soft agar at the time of treatment, due to inadequate
tumour disaggregation, may erroneously be scored as col-
onies during the colony counting (Rofstad et al., 1985).
However, if the necessary precautions are taken to avoid the
pitfalls, as described above in the Materials and methods
section, the assay gives reliable heat survival curves. Thus,
the shapes of the curves in Figures 2-4 were similar to those
of corresponding curves reported for tumour cell lines estab-
lished in monolayer culture. The reproducibility of the assay
Table I Plating efficiency in vitro of human tumour cells
Breast Malignant Squamous cell
carcinoma melanoma carcinoma
Tumour PE(%) Tumour PE(%) Tumour PE(%)
A.T.b 2.7c A.W. 4.9 B.B. 0.4
C.B. 0.5 B.I. 3.0 E.S. 0.9
D.K. 0.6 C.E. 2.8 F.V. 1.3
F.B. 1.1 D.N. 4.8 G.Z. 0.8
H.C. 3.6 E.A. 6.0 K.B. 3.0
K.S. 0.7 E.L. 10.1 K.P. 2.0
L.A. 0.9 G.B. 1.6 K.W. 2.8
L.R. 4.8 H.W. 2.3 N.E. 0.6
O.E. 0.9 J.S. 7.7 P.B. 0.3
P.U. 1.4 O.F. 20.4 P.Z. 3.2
R.M. 2.1 R.N. 15.1 R.F. 1.7
S.D. 0.8 T.J. 17.9 S.H. 1.4
S.W. 0.4 U.M. 1.9 T.M. 2.5
T.T. 0.8 V.I. 2.0 Z.R. 3.5
aPlating efficiency in soft agar. bThe letters do not refer to the initials
of the patients from whom the tumours were derived. cSingle
experiments or mean from two experiments.
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Figure 4 Survival curves for cells from human breast carcinoma (a,b), malignant melanoma (c,d) and squamous cell carcinoma of
the head and neck (e,f) heated in soft agar. Circles refer to cells given graded single heat treatments at 43.5°C and triangles to cells
given a conditioning heat treatment of 43.5°C for 60 min and, after a fractionation interval of 24 h, second graded heat treatments
at 43.5°C. 0, A, cells from newly prepared suspensions; 0, A, cells stored in liquid nitrogen. Each survival level was calculated
from the mean number of colonies in four tubes with heated and four tubes with unheated cells.
Table II Heat sensitivity in vitro of human tumour cells
Breast Malignant Squamous cell
carcinoma melanoma carcinoma
Tumour Do (min)a Tumour Do (min) Tumour Do (min)
A.T.b 30± 3c B.I. 54±4 F.V. 35±2
D.K. 59±7 D.N. 20±1 K.B. 31±3
F.B. 36±2 G.B. 42±2 K.W. 34±2
H.C. 28±3 H.W. 43±3 N.E. 49±3
L.R. 23±2 O.F. 26±3 P.B. 57±7
O.E. 43±4 R.N. 25±2 P.Z. 20±2
R.M. 45±2 T.J. 23±2 S.H. 50±5
S.W. 55±3 V.I. 63±4 Z.R. 20±2
aThecellswereheatedat43.5°C.bThelettersdo notrefer to theinitials
of the patients from whom the tumours were derived. cMean±s.e.
Survival curves were fitted to the data from a single or two independent
experiments by regression analysis. Data points in the range
30-240 minwereincluded intheanalysis,except fortheD.K., H.C. and
O.E. breast carcinomas and the H.W. and R.N. malignant melanomas,
where thedatapoints at 30 min werejudged to be in theshoulder region
and thus were omitted.
was adequate, as indicated by the coinciding results in
independent experiments performed with newly prepared cell
suspensions and cell suspensions stored in liquid nitrogen.
Moreover, cells from different tumours showed individual
and characteristic survival curves varying significantly in D..
These observations suggest that differences in heat sensitivity
and development of thermotolerance among cell populations
isolated directly from human tumour surgical specimens can
be identified by using the Courtenay assay, provided that (a)
single cell suspensions of sufficient quality can be prepared
and (b) the tumour cells show a sufficiently high plating
efficiency.
The number of tumour cells available for study is always
limited in experiments involving human tumour surgical
specimens; the size of a specimen and the cell yield determine
the cell number and hence the size of an experiment. Thus,
only some of the tumour specimens provided enough cells for
the experiments to be repeated. For the other tumours, the
heat sensitivity had to be determined from one survival
experiment only. Moreover, detailed studies of the kinetics of
thermotolerance and the magnitude of TTR were often not
possible. Experiments with three tumours, one of each his-
tological category, indicated that the thermotolerance was
close to its maximum magnitude 24 h after a conditioning
Table III Heat sensitivity in vitro of thermotolerant human tumour
cells
Breast Malignant Squamous cell
carcinoma melanoma carcinoma
Tumour Do (min)a Tumour Do (min) Tumour Do (min)
C.B.b 476+191c A.W. 141±23 B.B. 313±104
F.B. 135±19 B.I. 204±46 E.S. 238± 56
K.S. 132±13 C.E. 208±42 G.Z. 217±33
L.A. 159±20 E.A. 102± 13 K.P. 120± 12
P.U. 105±13 E.L. 455±170 R.F. 109±18
R.M. 370± 186 J.S. 200± 38 S.H. 400±267
S.D. 233±45 T.J. 175±25 T.M. 109± 13
T.T. 179±44 U.M. 140±24 Z.R. 87± 10
aThe cells were given a conditioning heat treatment of 43.5°C for
60 min, incubated at37°C for 24 h fordevelopmentofthermotolerance,
and then heated at 43.5°C. 'The letters do not refer to the initials ofthe
patients from whom the tumours were derived. cMean ± s.e. Survival
curves were fitted to the data from a single or two independent
experiments by regression analysis. Data points in the range
120-360 min (total heating time) were included in the analysis.HYPERTHERMIA OF HUMAN TUMOUR CELLS 27
10 cinoma, malignant melanoma and squamous cell carcinoma
Breast Malignant Sq. cell in these thermobiological parameters were not found. Histo-
carcinoma melanoma carcinoma logical category is therefore probably a poor parameter for
0.7 - assessment of clinical heat responsiveness of human tumours.
* However, the clinical heat responsiveness of tumours does
0o5L i * not depend only on cellular heat sensitivity and development
* 0 of thermotolerance. Other tumour parameters, e.g.
0.0 *O physiological and vascular conditions, rate of thermo-
s tolerance decay and radiosensitization by heat, are probably
0.3 - 0 % also important. It is possible that these parameters differ
| @ ~ ~ among the three tumour categories studied here. Never-
* 0 theless, the present study indicates that breast carcinoma,
0.2 - malignant melanoma and squamous cell carcinoma are
* * equally good candidates for clinical trials aimed at investigat-
* P ing the potential usefulness of hyperthermia as a treatment
*0 0 0 modality for cancer.
* * On the other hand, the heat sensitivity of single-heated as
01 0 * well as thermotolerant cells was found to differ considerably
0* among individual tumours, irrespective of histological
0 07
- category. The inter-tumour heterogeneity in heat respons-
iveness in vivo is probably even larger than indicated by the
005_
present in vitro study. Cellular heat sensitivity and develop-
ment of thermotolerance depend on pH, nutritional condi-
Tumour type tions and perhaps also on oxygen concentration (Gerweck,
5 Surviving fractions for cells from human breast car- 1977; Li & Hahn, 1980; Nielsen, 1981), and these
malignant melanoma and squamous cell carcinoma of physiological parameters may differ within as well as among
.d and neck heated at 43.5C for 60 min in soft agar. tumours. Moreover, the heat responsiveness of tumours
refer to different tumours. depends on the architecture of the vascular network; vascular
cooling may cause heterogeneous tumour heating (Hill &
DO Denekamp, 1982; Reinhold et al., 1985) and heat-induced
capillary collapse may cause secondary tumour cell death
* Breast ca. (Song et al., 1980; Rofstad & Brustad, 1986b). Vascular
do _ * Mal. melanoma heterogeneity within and among tumours is well documented
* Sq cell ca (Solesvik et al., 1982; Vaupel & Gabbert, 1986; Nishimura et
)Oc al., 1988). Consequently, the inter-tumour heterogeneity in
heat sensitivity and development of thermotolerance observed
here may, under in vivo conditions, be enhanced by the
Do _ tumour microenvironment.
The heat sensitivity of the tumour cells after development
)O .of thermotolerance as well as the TTR showed no clear zo _ 1 ~~~~~~~~~~~correlation to the surviving fraction after the conditioning
IILI E heat treatment, indicating that heat sensitivity of cells in the
Do - '0 , t ^ ,thermotolerant state is independent of that in the normal
l I j *4 , state. This observation may be a reflection of 'random assort-
ment of tumour characteristics' as proposed by Foulds
Do - v ** (1969). Similar observations have been made for experimental
tumours. Urano et al. (1982) compared maximum TTR and
0 ____ heat sensitivity in three murine tumour lines heated and
1 0 0.6 04 0.2 0.1 0.06 004 assayed in vivo and found no relationship. Five human
melanoma xenograft lines were studied in vivo in our
Surviving fraction laboratory, and this study showed no correlation between
6 Heat sensitivity (Do) for thermotolerant cells from maximum TTR and specific growth delay after the condition-
breast carcinoma (A), malignant melanoma (@) and ing heat treatment (Rofstad, 1989), in agreement with the
us cell carcinoma of the head and neck (U) heated at data in Figure 6.
n soft agar versus surviving fraction after the conditioning The present study suggests that individual tumours may
atment (43.5C for 60 min). The cells were incubated at differ considerably in clinical heat responsiveness, irrespective
r 24h after the conditioning heat treatment for develop- of histological origin. Thus, there is a need for adequate
thermotolerance. stratification parameters in clinical trials studying hyper-
thermia as an adjunct to radiation therapy and/or
chemotherapy. A rapid in vitro predictive assay for heat
itment of 43.5°C for 60 min (Figure 1). Comparable, responsiveness of tumours would have been particularly
^e detailed, studies with cells isolated from human useful. However, the development of a simple, clinically
la xenografts also showed maximum thermotoler- useful assay is rendered difficult by several conditions: (a)
)ut 24 h after the same conditioning heat treatment heat sensitivity of cells after development of thermotolerance
I et al., 1984). The heat sensitivity of cells made is independent of that in the normal state (Figure 6); (b) heat
)lerant with 43.5'C for 60 min was therefore always sensitivity of cells, whether thermotolerant or not, is modified
24 h after the conditioning heat treatment. However, significantly by the physiological conditions in the tumour
e did probably not correspond to maximum ther- microenvironment (Gerweck, 1977; Li & Hahn, 1980;
nce for all tumours, and this may have contributed Nielsen, 1981); (c) heat responsiveness of tumours is deter-
ise the inter-tumour heterogeneity in heat sensitivity mined partly by the architecture and the functionality of the
iotolerant cells. vascular network (Song et al., 1980; Rofstad & Brustad,
nportant objective of the present work was to inves- 1986b; Nishimura et al., 1988); and (d) rate of thermo-
hether cellular heat sensitivity and development of tolerance decay in tumours is governed mainly by tumour
lerance vary between tumour types of different his- growth parameters rather than by intrinsic characteristics of
origin. Significant differences between breast car- the tumour cells (Rofstad, 1989). Consequently, a predictive
c
0
0)
C
U)
Figure
cinoma,
the hea
Points 1
-
E
0 3C
Figure 4
human
squamo'
43.5'C i
heat tre
37°C foi
ment of
heat trea
but mor
melanort
ance abc
(Rofstad
thermotc
studied I
this time
motolera
to increa
of therm
One in
tigate wl
thermoto
tological
7(
6C
5C
4C
2(
1c28 E.K. ROFSTAD
assay for heat responsiveness of tumours must probably take
into consideration intrinsic characteristics of the tumour cells
in the normal and thermotolerant state as well as micro-
environmental, vascular and growth characteristics of the
tumours in vivo.
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